Optimization of LpxC Inhibitors for Antibacterial Activity and Cardiovascular Safety

被引:60
作者
Cohen, Frederick [1 ]
Aggen, James B. [1 ]
Andrews, Logan D. [1 ]
Assar, Zahra [2 ]
Boggs, Jen [1 ]
Choi, Taylor [1 ]
Dozzo, Paola [1 ]
Easterday, Ashton N. [1 ]
Haglund, Cat M. [1 ]
Hildebrandt, Darin J. [1 ]
Holt, Melissa C. [2 ]
Joly, Kristin [3 ]
Jubb, Adrian [1 ]
Kamal, Zeeshan [4 ]
Kane, Timothy R. [1 ]
Konradi, Andrei W. [5 ]
Krause, Kevin M. [1 ]
Linsell, Martin S. [1 ]
Machajewski, Timothy D. [1 ]
Miroshnikova, Olga [4 ]
Moser, Heinz E. [1 ]
Nieto, Vincent [1 ]
Thu Phan [4 ]
Plato, Craig [3 ]
Serio, Alisa W. [1 ]
Seroogy, Julie [1 ]
Shakhmin, Anton [4 ]
Stein, Adam J. [2 ]
Sun, Alex D. [4 ]
Sviridov, Serguei [4 ]
Wang, Zhan [4 ]
Wlasichuk, Kenneth [1 ]
Yang, Wen [4 ]
Zhou, Xiaoming [6 ]
Zhu, Hai [4 ]
Cirz, Ryan T. [1 ]
机构
[1] Achaogen Inc, 1 Tower Pl,Suite 400, San Francisco, CA 94080 USA
[2] Cayman Chem Co, 1180 East Ellsworth, Ann Arbor, MI 48108 USA
[3] Plato BioPharma Inc, Unit 300, 7581 West 103rd Ave, Westminster, CO 80021 USA
[4] Nanosyn Inc, 3100 Cent Expressway, Santa Clara, CA 95051 USA
[5] Konradi Mol, 30 Victoria Rd, Burlingame, CA 94010 USA
[6] Pharmaron Inc, BDA, 6 Tai He Rd, Beijing 100176, Peoples R China
基金
美国国家卫生研究院;
关键词
amines; antibiotics; inhibitors; LpxC; prodrugs; Pseudomonas; zwitterions; DRUGS;
D O I
10.1002/cmdc.201900287
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase (LpxC) is a Zn2+ deacetylase that is essential for the survival of most pathogenic Gram-negative bacteria. ACHN-975 (N-((S)-3-amino-1-(hydroxyamino)-3-methyl-1-oxobutan-2-yl)-4-(((1R,2R)-2-(hydroxymethyl)cyclopropyl)buta-1,3-diyn-1-yl)benzamide) was the first LpxC inhibitor to reach human clinical testing and was discovered to have a dose-limiting cardiovascular toxicity of transient hypotension without compensatory tachycardia. Herein we report the effort beyond ACHN-975 to discover LpxC inhibitors optimized for enzyme potency, antibacterial activity, pharmacokinetics, and cardiovascular safety. Based on its overall profile, compound 26 (LPXC-516, (S)-N-(2-(hydroxyamino)-1-(3-methoxy-1,1-dioxidothietan-3-yl)-2-oxoethyl)-4-(6-hydroxyhexa-1,3-diyn-1-yl)benzamide) was chosen for further development. A phosphate prodrug of 26 was developed that provided a solubility of >30 mg mL(-1) for parenteral administration and conversion into the active drug with a t(1/2) of approximately two minutes. Unexpectedly, and despite our optimization efforts, the prodrug of 26 still possesses a therapeutic window insufficient to support further clinical development.
引用
收藏
页码:1560 / 1572
页数:13
相关论文
共 26 条
[1]  
[Anonymous], 2007, PRODRUGS BIOTECHNOLO, DOI DOI 10.1007/978-0-387-49785-3_16
[2]  
[Anonymous], 2015, Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically: M07-A10
[3]  
Approved Standard
[4]  
[Anonymous], 2013, Antibiotic resistance threats in the United States, 2013
[5]   Re-estimating annual deaths due to multidrug-resistant organism infections [J].
Burnham, Jason P. ;
Olsen, Margaret A. ;
Kollef, Marin H. .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2019, 40 (01) :112-113
[6]   Pan-Resistant New Delhi Metallo-Beta-Lactamase-Producing Klebsiella pneumoniae - Washoe County, Nevada, 2016 [J].
Chen, Lei ;
Todd, Randall ;
Kiehlbauch, Julia ;
Walters, Maroya ;
Kallen, Alexander .
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2017, 66 (01) :33-33
[7]  
Cohen F., 2017, Int. PCT Pub., Patent No. [WO2017223349, 2017223349]
[8]   THE IMPORTANCE OF THE GEOMETRIC MEAN MIC [J].
DAVIES, BI .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1990, 25 (03) :471-472
[9]   Antibacterial Drug Discovery Targeting the Lipopolysaccharide Biosynthetic Enzyme LpxC [J].
Erwin, Alice L. .
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2016, 6 (07)
[10]   Exploring the UDP pocket of LpxC through amino acid analogs [J].
Hale, Michael R. ;
Hill, Pamela ;
Lahiri, Sushmita ;
Miller, Matthew D. ;
Ross, Philip ;
Alm, Richard ;
Gao, Ning ;
Kutschke, Amy ;
Johnstone, Michele ;
Prince, Bryan ;
Thresher, Jason ;
Yang, Wei .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (08) :2362-2367